Cytokinetics Inc (CYTK)
66.82
+1.24
(+1.90%)
USD |
NASDAQ |
Apr 24, 16:00
66.82
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Revenue (TTM): 7.53M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.53M |
| September 30, 2023 | 7.815M |
| June 30, 2023 | 9.952M |
| March 31, 2023 | 98.05M |
| December 31, 2022 | 94.59M |
| September 30, 2022 | 148.23M |
| June 30, 2022 | 151.15M |
| March 31, 2022 | 65.03M |
| December 31, 2021 | 70.43M |
| September 30, 2021 | 21.55M |
| June 30, 2021 | 57.80M |
| March 31, 2021 | 58.55M |
| December 31, 2020 | 55.83M |
| September 30, 2020 | 54.32M |
| June 30, 2020 | 18.68M |
| March 31, 2020 | 22.23M |
| December 31, 2019 | 26.87M |
| September 30, 2019 | 31.03M |
| June 30, 2019 | 35.62M |
| March 31, 2019 | 34.70M |
| December 31, 2018 | 31.50M |
| September 30, 2018 | 22.11M |
| June 30, 2018 | 17.64M |
| March 31, 2018 | 14.48M |
| December 31, 2017 | 13.37M |
| Date | Value |
|---|---|
| September 30, 2017 | 46.52M |
| June 30, 2017 | 99.39M |
| March 31, 2017 | 102.14M |
| December 31, 2016 | 106.41M |
| September 30, 2016 | 83.03M |
| June 30, 2016 | 31.92M |
| March 31, 2016 | 32.66M |
| December 31, 2015 | 28.66M |
| September 30, 2015 | 40.66M |
| June 30, 2015 | 42.13M |
| March 31, 2015 | 43.38M |
| December 31, 2014 | 46.94M |
| September 30, 2014 | 49.53M |
| June 30, 2014 | 44.58M |
| March 31, 2014 | 37.81M |
| December 31, 2013 | 30.65M |
| September 30, 2013 | 8.483M |
| June 30, 2013 | 5.728M |
| March 31, 2013 | 6.56M |
| December 31, 2012 | 7.559M |
| September 30, 2012 | 6.132M |
| June 30, 2012 | 5.845M |
| March 31, 2012 | 5.057M |
| December 31, 2011 | 4.00M |
| September 30, 2011 | 4.342M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
7.53M
Minimum
Dec 2023
151.15M
Maximum
Jun 2022
54.49M
Average
54.32M
Median
Sep 2020
Revenue (TTM) Benchmarks
| Amgen Inc | 28.19B |
| Johnson & Johnson | 89.66B |
| Eli Lilly and Co | 34.12B |
| Viking Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |